Short communicationAssociation between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort
Introduction
The estimated glomerular filtration rate (eGFR) is commonly used to define renal function and identify individuals with chronic kidney disease (CKD). The Kidney Disease Outcome Quality Initiative (K/DOQI) defined CKD as the presence of renal impairment with an eGFR < 60 (National Kidney Foundation, 2002). Based on this definition the EPIRCE study (Epidemiology of Chronic Kidney Disease in Spain) estimated that approximately 10% of the Spanish adult population had some degree of CKD, and similar values were also estimated from other epidemiological studies (Coresh et al., 2007, Otero et al., 2010). CKD is a strong predictor of end stage renal disease (ESRD), cardiovascular morbidity, and mortality. In addition to well known risk factors such as hypertension and diabetes, recent genome wide association studies (GWAs) linked several single nucleotide polymorphisms (SNPs) to eGFR and prevalent CKD (Köttgen et al., 2009, Köttgen et al., 2010). Some of these SNPs were also associated with the progression to ESRD (Böger et al., 2011).
The MYH9 gene encodes a myosin heavy chain protein expressed in glomerular podocytes and mesangial cells (Marini et al., 2006). Recent studies linked MYH9 SNPs/haplotypes to the risk of developing focal segmental glomerulosclerosis (FSGS), hypertensive nephropathy, and non-diabetic ESRD among African and Hispanic Americans (Behar et al., 2010, Freedman et al., 2009a, Freedman et al., 2009b, Kao et al., 2008, Kopp et al., 2008). This association was not replicated among American Indians, a fact that could be partly explained by differences in the prevalence of risk factors for CKD between the populations (Franceschini et al., 2010).
Among individuals of European ascent, MYH9 polymorphisms have been linked to kidney function, non-diabetic and diabetic nephropathy, and idiopathic FSGS (Cooke et al., 2012, Kao et al., 2008, O'Seaghdha et al., 2011, Pattaro et al., 2009). Our objective was to define the effect of common MYH9 SNPs on renal function in a Spanish cohort of healthy elderly individuals.
Section snippets
Study population and data collection
This study was approved by the Ethical Committee of Hospital Universitario Central de Asturias (HUCA) and all the participants signed an informed consent. The RENASTUR was a cross-sectional study to evaluate the association between gene polymorphisms and renal function in elderly people. A total of 592 individuals aged 55–85, all Caucasian, non-related, and from the region of Asturias (Northern Spain, total population one million), were randomly chosen from the general population in the period
Results
Table 1 summarizes the main characteristics in the whole RENASTUR cohort, and in those with eGFR < 60 (n = 77) and ≥ 60 (n = 515) ml/min/1.73 m2. The genotype frequencies for the two MYH9 SNPs did not deviate from Hardy–Weinberg equilibrium in the two groups.
In the univariate analysis the next variables were significantly associated with an eGFR < 60: age (p < 0.001), male (p = 0.04), type 2 diabetes (p < 0.001), total cholesterol (p = 0.03), LDL-cholesterol (p = 0.05), and MYH9 rs3752462 T allele (dominant effect,
Discussion
CKD is a major cause of morbidity and mortality, and is thus considered an important community health problem. According to the EPIRCE study approximately 10% of the Spanish adult population had some degree of CKD (Otero et al., 2010). This was in agreement with our findings in the RENASTUR cohort, with 10% of the participants showing an eGFR < 60 ml/min/1.73 m2. The search for markers associated with CKD is important to identify individuals at risk for ESRD and cardiovascular events, which could
Financial disclosure
All the authors declare that they have no conflicts of interest related with this work.
Contributorship
All the authors contributed to this work by recruiting the population cohort (S.T., K.M., M.I.R., F.O., B.D., R.M., E.S., J.A.) or performing the genetic and statistical analysis (B.T., J.G., E.C., V.A.).
Acknowledgments
This work was supported by grant Red de Investigación Renal-REDINREN, and Fundación Investigación Científica y Técnica (FICYT)–European FEDER funds. This work was partly supported by grant FIS PI10/01971 (F.O.).
References (27)
Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H
Mitochondrion
(2011)Genome-wide linkage analysis of serum creatinine in three isolated European populations
Kidney Int.
(2009)Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes
J. Am. Soc. Nephrol.
(2002)- et al.
African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans
Hum Mol Genet
(2010) Association of eGFR-related loci identified by GWAS with incident CKD and ESRD
PLoS Genet.
(2011)- et al.
The spectrum of MYH9-associated nephropathy
Clin. J. Am. Soc. Nephrol.
(2010) Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans
Nephrol. Dial. Transplant.
(2012)Prevalence of chronic kidney disease in the United States
JAMA
(2007)Predictors of new-onset kidney disease in a community based population
JAMA
(2004)The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study
Hum. Genet.
(2010)
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD
Nephrol. Dial. Transplant.
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study
Am. J. Nephrol.
Using mitochondrial DNA to test the hypothesis of a European post-glacial human recolonization from the Franco-Cantabrian refuge
Heredity
Cited by (22)
Simultaneous genotyping of rs3752462 and rs4821480 at non-muscle myosin-9 in diabetic nephropathy
2021, Gene ReportsCitation Excerpt :However, a statistically significant decrease of eGFR was present in the TT genotype compared to that in the other genotypes. This is in concurrence with a study done by Tavira et al. (2013), who found a significant statistical decrease of eGFR in TT genotype (p = 0.003) and T allele (p = 0.03) and they also confirmed that the existence of C allele is protective for the progression of CKD among Caucasian populations. In this study, genotype frequency and allelic distribution of MYH9 SNP (rs4821480) were consistent with the Hardy–Weinberg equilibrium (HWE).
Association of MYH9 rs3752462 and rs5756168 Polymorphisms With Transplanted Kidney Artery Stenosis
2016, Transplantation ProceedingsCitation Excerpt :As shown in Fig 1, the influence of above-mentioned SNPs on TRAS became evident in the early post-transplantation period, which suggests that the advent of stenosis is more likely to be associated with dysfunctional healing than with atherosclerotic-like remodeling. Bearing in mind the excessive expression of nonmuscle myosin heavy chain in adventitia and intima resulting from mechanic injury to the vessel wall [8], the correlation identified by our study may be considered as possibly pointing to the pathomechanism that underlies the association of selected MYH9 SNPs and glomerular filtration loss [3–7]. In studies analyzing clinical pictures of functional MYH9 mutations (so called MYH9-related disorders), in those cases where kidney biopsy was available the microscopic appearance consisted of mesangial cell proliferation and matrix accumulation, focal and segmental glomerulosclerosis, and chronic interstitial injury [10–12].
KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort
2016, Molecular and Cellular EndocrinologyCitation Excerpt :A total of 681 individuals from the RENASTUR cohort were genotyped. All them were Caucasian, aged 65–85 years (45% male) and from the region of Asturias (Northern Spain, total population one million), and were recruited through Primary Health Care Centers to evaluate renal function in healthy elderly people (Tavira et al., 2013; Coto et al., 2014). Individuals with a history of chronic renal disease were not eligible for the study.
Hypertensive nephropathy - A yet unsolved problem
2014, Polish Annals of MedicineCitation Excerpt :Similarly, O'Seaghdha et al.39 in their study reported relationship between MYH9 gene polymorphism with increased risk of non-diabetic renal disease in European subjects, who were participants of Framingham Heart Study and Atherosclerotic Risk in Communities Study. In the study of Tavira et al.40 MYH9 gene polymorphism was an independent risk factor for reduced eGFR in a group of 595 Spanish Caucasians. Representation of APOL1 gene variants is very low in Caucasian population and no correlation between polymorphism of this gene and kidney diseases in this population was proven.
A CLCNKA polymorphism (rs10927887; p.Arg83Gly) previously linked to heart failure is associated with the estimated glomerular filtration rate in the RENASTUR cohort
2013, GeneCitation Excerpt :All the participants were evaluated by a qualified physician, who was also responsible for obtaining the main epidemiological and biochemical values (Table 1). The main characteristics of this cohort were reported elsewhere (Coto et al., 2013; Tavira et al., 2013). Briefly, smoking (ever/never smoked) was self reported.